Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective
Amos J. de Jong, Tessa I. van Rijssel, Mira G. P. Zuidgeest, et al.
Clinical Pharmacology & Therapeutics (2022) Vol. 112, Iss. 2, pp. 344-352
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Decentralized clinical trials (DCTs): A few ethical considerations
Carlo Petrini, Chiara Mannelli, Luciana Riva, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 47
Revolutionizing clinical trials: the role of AI in accelerating medical breakthroughs
Hitesh Chopra, Annu Annu, Dong Kyoo Shin, et al.
International Journal of Surgery (2023) Vol. 109, Iss. 12, pp. 4211-4220
Open Access | Times Cited: 40
Using Patient Perspectives to Inform Better Clinical Trial Design and Conduct: Current Trends and Future Directions
Stuart Faulkner, F. Somers, Mathieu Boudes, et al.
Pharmaceutical Medicine (2023) Vol. 37, Iss. 2, pp. 129-138
Open Access | Times Cited: 27
Decentralized Clinical Trials in the Era of Real‐World Evidence: A Statistical Perspective
Jie Chen, Junrui Di, Nadia Daizadeh, et al.
Clinical and Translational Science (2025) Vol. 18, Iss. 2
Open Access | Times Cited: 1
Next-Generation Cognitive-Behavioral Therapy for Depression: Integrating Digital Tools, Teletherapy, and Personalization for Enhanced Mental Health Outcomes
Evgenia Gkintoni, Stephanos P. Vassilopoulos, Γεώργιος Νικολάου
Medicina (2025) Vol. 61, Iss. 3, pp. 431-431
Open Access | Times Cited: 1
The impact of operational trial approaches on representativeness: Comparison of decentralized clinical trial participants, conventional trial participants, and patients in daily practice
Amos J. de Jong, Mira G. P. Zuidgeest, Yared Santa‐Ana‐Téllez, et al.
Drug Discovery Today (2025), pp. 104304-104304
Open Access
Exploration of Using an Open‐Source Large Language Model for Analyzing Trial Information: A Case Study of Clinical Trials With Decentralized Elements
Ki Young Huh, Ildae Song, Yoonjin Kim, et al.
Clinical and Translational Science (2025) Vol. 18, Iss. 3
Open Access
Exploring implementation challenges of decentralized clinical trials: A qualitative study of policy stakeholder perspectives in Denmark
Ida Hestbjerg, Ditte Bonde Stanek, Ulrik Bak Kirk, et al.
Digital Health (2025) Vol. 11
Open Access
Pharmacogenomics and rare diseases: optimizing drug development and personalized therapeutics
Youssef M. Roman
Pharmacogenomics (2025), pp. 1-8
Closed Access
The value of decentralized clinical trials: Inclusion, accessibility, and innovation
Girardin Jean–Louis, Azizi Seixas
Science (2024) Vol. 385, Iss. 6711
Closed Access | Times Cited: 4
Artificial intelligence can improve patients’ experience in decentralized clinical trials
Kevin A. Thomas, Łukasz Kidziński
Nature Medicine (2022) Vol. 28, Iss. 12, pp. 2462-2463
Open Access | Times Cited: 15
Increasing patient participation in oncology clinical trials
Jie Chen, Ying Lü, Shivaani Kummar
Cancer Medicine (2022) Vol. 12, Iss. 3, pp. 2219-2226
Open Access | Times Cited: 13
Telemedicine and Cancer Clinical Research
Mitchell S. von Itzstein, Mary Gwin, Arjun Gupta, et al.
The Cancer Journal (2024) Vol. 30, Iss. 1, pp. 22-26
Closed Access | Times Cited: 2
The Evolution of Drug Regulatory Sciences in the Netherlands: More than a Country Report
Anna M.G. Pasmooij, Peter G. M. Mol, Jacob Cornelis Bot, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 1, pp. 64-71
Open Access | Times Cited: 2
A global pilot comparative, cross-sectional study of clinical research nurses/research midwives: Definition, knowledge base, and communication skills related to the conduct of decentralized clinical trials
Elizabeth A. Johnson, Gordon Hill, Hazel Smith, et al.
Journal of Clinical and Translational Science (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 2
A Fully Decentralized Randomized Controlled Study of As-Needed Albuterol–Budesonide Fixed-Dose Inhaler in Mild Asthma: The BATURA Study Design
Craig LaForce, Frank C. Albers, Mark E. Cooper, et al.
Journal of Asthma and Allergy (2024) Vol. Volume 17, pp. 801-811
Open Access | Times Cited: 2
Recommendations to promote equity, diversity and inclusion in decentralized clinical trials
Olalekan Lee Aiyegbusi, Samantha Cruz Rivera, Paul Kamudoni, et al.
Nature Medicine (2024) Vol. 30, Iss. 11, pp. 3075-3084
Open Access | Times Cited: 2
Design and Execution of Sustainable Decentralized Clinical Trials
Pritibha Singh, Andrea M. Burden, Fanni Natanegara, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 114, Iss. 4, pp. 802-809
Open Access | Times Cited: 5
Opportunities and Challenges for Decentralized Clinical Trial Approaches: European Health Technology Assessment Perspective
Amos J. de Jong, Nadi Shahid, Mira G. P. Zuidgeest, et al.
Value in Health (2023) Vol. 27, Iss. 3, pp. 294-300
Open Access | Times Cited: 5
A Prototype Model of Zero Trust Architecture Blockchain with EigenTrust-Based Practical Byzantine Fault Tolerance Protocol to Manage Decentralized Clinical Trials
Ashok Peepliwal, Hari Mohan Pandey, Surya Prakash, et al.
Blockchain Research and Applications (2024), pp. 100232-100232
Open Access | Times Cited: 1
Informing a European guidance framework on electronic informed consent in clinical research: a qualitative study
Evelien De Sutter, Pascal Borry, Isabelle Huys, et al.
BMC Health Services Research (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Decentralized Clinical Trials: Potentials for Equity in Digital Health
Ditte Weber, Christian Nøhr
Studies in health technology and informatics (2023)
Open Access | Times Cited: 4
Direct‐to‐participant investigational medicinal product supply in clinical trials in Europe: Exploring the experiences of sponsors, site staff and couriers
Amos J. de Jong, Yared Santa‐Ana‐Téllez, Mira G. P. Zuidgeest, et al.
British Journal of Clinical Pharmacology (2023) Vol. 89, Iss. 12, pp. 3512-3522
Open Access | Times Cited: 4
Feasibility study for a fully decentralized clinical trial in participants with functional constipation symptoms
Ki Young Huh, Woo Kyung Chung, Jiyeon Park, et al.
Clinical and Translational Science (2023) Vol. 16, Iss. 11, pp. 2177-2188
Open Access | Times Cited: 4
Decentralized research technology use in multicenter clinical research studies based at U.S. academic research centers
Mollie Cummins, Jeri Burr, Lisa Young, et al.
Journal of Clinical and Translational Science (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top